LNG-1 Implant

Alternative Name: One-year LNG Single Rod Implant

Description: A single-rod one-year silastic implant containing 127 mg levonorgestrel (LNG).

Product Details

User: Female

Hormonal: Yes

Delivery Method: Subdermal

Duration Type: Long-acting

Duration: One year

Dose: 127 mg

Active Pharmaceutical Ingredient (API):
  • levonorgestrel

Inactive material: silastic

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: CONRAD, FEI Technologies

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Phase I

Active Development: No

Status Details:
  • Phase I found lower serum LNG levels and less favorable bleeding patterns, so work discontinued.

Additional Information

Footnotes:
  • FEI Women's Health LLC was acquired by Duramed Pharmaceuticals, Inc. in 2005.

Vertical Tabs

Print